Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer pat...

by Lisa Salvatore, Lisa Salvatore, Maria Bensi, Maria Bensi, Raffaella Vivolo, Raffaella Vivolo, Ina Valeria Zurlo, Ina Valeria Zurlo, Emanuela Dell’Aquila, Emanuela Dell’Aquila, Roberta Grande, Roberta Grande, Annunziato Anghelone, Annunziato Anghelone, Alessandra Emiliani, Fabrizio Citarella, Maria Alessandra Calegari, Marta Ribelli, Michele Basso, Carmelo Pozzo, Giampaolo Tortora, Giampaolo Tortora
Published 2023-02-01

Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.

by Roberta Grande, Domenico Corsi, Raffaello Mancini, Donatello Gemma, Fabrizio Ciancola, Isabella Sperduti, Lorena Rossi, Agnese Fabbri, Maria G Diodoro, Enzo Ruggeri, Germano Zampa, Sara Bianchetti, Teresa Gamucci
Published 2013-01-01

Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.

by Roberta Grande, Clara Natoli, Fabrizio Ciancola, Donatello Gemma, Arianna Pellegrino, Ida Pavese, Carlo Garufi, Luigi Di Lauro, Domenico Corsi, Diego Signorelli, Isabella Sperduti, Giada Cortese, Emanuela Risi, Federica Morano, Domenico Sergi, Carlo Signorelli, Enzo Maria Ruggeri, Germano Zampa, Marco Russano, Teresa Gamucci
Published 2016-01-01